Kala Pharmaceuticals Inc

NASDAQ:KALA

0.38

0.00 (-0.16%)

Mergers / Acquisitions

Kala Announces Entry Into Definitive Agreement To Sell Eysuvis And Inveltys To Alcon

Published: 05/23/2022 04:26 GMT

Kala Pharmaceuticals Inc (KALA) - Kala Announces Entry Into Definitive Agreement to Sell Eysuvis® and Inveltys® to Alcon Inc.kala Pharmaceuticals - Kala Will Receive an Upfront Payment of $60 Million and Will Be Eligible to Receive Commercial-based Sales Milestone Payments.
Anticipates Transaction Will Close in Q3 of 2022.